Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $224,325 - $249,468
-956 Closed
0 $0
Q2 2020

Aug 10, 2020

SELL
$197.81 - $242.74 $28,682 - $35,197
-145 Reduced 13.17%
956 $225,000
Q4 2019

Jan 17, 2020

SELL
$189.21 - $243.2 $32,733 - $42,073
-173 Reduced 13.58%
1,101 $265,000
Q3 2019

Oct 15, 2019

BUY
$174.11 - $208.62 $221,816 - $265,781
1,274 New
1,274 $247,000
Q1 2019

Apr 24, 2019

SELL
$180.87 - $203.88 $333,343 - $375,750
-1,843 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
$178.4 - $208.25 $7,671 - $8,954
-43 Reduced 2.28%
1,843 $217,000
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $66,148 - $74,573
357 Added 23.35%
1,886 $240,000
Q2 2018

Aug 15, 2018

SELL
$166.05 - $186.51 $74,556 - $83,742
-449 Reduced 22.7%
1,529 $282,000
Q1 2018

May 10, 2018

BUY
$169.43 - $198.0 $335,132 - $391,644
1,978 New
1,978 $333,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bridgeworth, LLC Portfolio

Follow Bridgeworth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeworth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeworth, LLC with notifications on news.